生物源
rat
品質等級
抗體表格
purified immunoglobulin
抗體產品種類
primary antibodies
無性繁殖
3C1, monoclonal
物種活性
human
技術
dot blot: suitable
flow cytometry: suitable
immunocytochemistry: suitable
immunoprecipitation (IP): suitable
western blot: suitable
同型
IgG1κ
NCBI登錄號
UniProt登錄號
運輸包裝
ambient
目標翻譯後修改
unmodified
基因資訊
human ... MNDA(4332)
一般說明
Myeloid cell nuclear differentiation antigen (UniProt P41218) is encoded by the MNDA gene (Gene ID 4332) in human. MNDA is a member of the interferon-inducible p200 (IFI-200) family of proteins with a conserved HIN-200 domain (human MNDA a.a. 196-394) that mediate interaction with proteins and DNA. IFI-200 members possess antimicrobial, cell growth regulatory, differential regulatory and immunomodulatory properties. In bone marrow-derived- and mature neutrophils, MNDA is predominantly located in the nucleus. MNDA is cleaved by caspases in neutrophils undergoing apoptosis and relocated to the cytoplasm. MNDA is downregulated in myelodysplastic syndrome and completely absent in a mouse strain susceptible to B-cell plasmacytoma, while being markedly (1,000-fold) upregulated in a mouse strain resistant to B-cell plasmacytoma. Originally thought to be restricted to, myeloid cells, MNDA and other IFI-200 family members are also found to be expressed in a variety of non-myeloid cell types. MNDA is highly expressed in normal bone tissue, while being at markedly low levels in osteosarcoma cells. MNDA overexpression is shown to induce apoptosis, inhibit proliferation, and reduce the migration of osteosarcoma cells.
特異性
Clone 3C1 reacted with both denatured and non-denatured MNDA. Clone 3C1 reacted with nuclear extract from NMDA-expressing HL-60, but not non-MNDA-expressing BII, human myeloid leukemia cells (Hudson, C.R., et al. (1988). Hybridoma. 7(6):541-553).
免疫原
Human peripheral blood granulocyte nuclei.
應用
Detect MNDA using this rat monoclonal Anti-MNDA Antibody, clone 3C1, Cat. No. MABC1170, validated for use in Dot Blot, Flow Cytometry, Immunocytochemistry, Immunoprecipitation, and Western Blotting.
Dot Blot Analysis: Clone 3C1 hybridoma culture supernatant reacted with nuclear extract from HL-60, but not BII, human myeloid leukemia cells (Hudson, C.R., et al. (1988). Hybridoma. 7(6):541-553).
Flow Cytometry Analysis: A representative lot (pre-conjugated with Alexa Fluor™ 488) detected MNDA expression among the granulocyte-macrophage (G-M) progenitors, but not among the nucleated red blood cells (nRBCs) and lymphoid cells in control and myelodysplastic syndromes (MDS) human marrow aspirates. A G-M progenitor cell population with downregulated MNDA expression was detected in most marrow samples from MDS cases and some MDS cases contain MNDA-negative G-M progenitor cells (Briggs, R.C., et al. (2006). Cancer Res. 66(9):4645-4651).
Immunocytochemistry Analysis: A representative lot detected MNDA nuclear immunoreactivity among HL-60 cells and NMDA-transfected, but not untransfected K562 cells. MNDA-negative HL-60 cells increased with time in cultures maintained without fresh medium for an extended period of time. MNDA translocated from nucleus to cytoplasm beginning at 3 hours and completed 4 hours following H2O2 addition to HL-60 cells (Briggs, R.C., et al. (2006). Cancer Res. 66(9):4645-4651).
Immunoprecipitation Analysis: A representative lot immunoprecipitated MNDA from HL-60 nuclear extract (Hudson, C.R., et al. (1988). Hybridoma. 7(6):541-553).
Western Blotting Analysis: A representative lot detected a time-dependent loss of MNDA in HL-60 cell lysate beginning at 4 hours following H2O2 treatment (Briggs, R.C., et al. (2006). Cancer Res. 66(9):4645-4651).
Western Blotting Analysis: Clone 3C1 hybridoma culture supernatant detected MNDA in HL-60 nuclear extract (Hudson, C.R., et al. (1988). Hybridoma. 7(6):541-553).
Flow Cytometry Analysis: A representative lot (pre-conjugated with Alexa Fluor™ 488) detected MNDA expression among the granulocyte-macrophage (G-M) progenitors, but not among the nucleated red blood cells (nRBCs) and lymphoid cells in control and myelodysplastic syndromes (MDS) human marrow aspirates. A G-M progenitor cell population with downregulated MNDA expression was detected in most marrow samples from MDS cases and some MDS cases contain MNDA-negative G-M progenitor cells (Briggs, R.C., et al. (2006). Cancer Res. 66(9):4645-4651).
Immunocytochemistry Analysis: A representative lot detected MNDA nuclear immunoreactivity among HL-60 cells and NMDA-transfected, but not untransfected K562 cells. MNDA-negative HL-60 cells increased with time in cultures maintained without fresh medium for an extended period of time. MNDA translocated from nucleus to cytoplasm beginning at 3 hours and completed 4 hours following H2O2 addition to HL-60 cells (Briggs, R.C., et al. (2006). Cancer Res. 66(9):4645-4651).
Immunoprecipitation Analysis: A representative lot immunoprecipitated MNDA from HL-60 nuclear extract (Hudson, C.R., et al. (1988). Hybridoma. 7(6):541-553).
Western Blotting Analysis: A representative lot detected a time-dependent loss of MNDA in HL-60 cell lysate beginning at 4 hours following H2O2 treatment (Briggs, R.C., et al. (2006). Cancer Res. 66(9):4645-4651).
Western Blotting Analysis: Clone 3C1 hybridoma culture supernatant detected MNDA in HL-60 nuclear extract (Hudson, C.R., et al. (1988). Hybridoma. 7(6):541-553).
Research Category
Apoptosis & Cancer
Apoptosis & Cancer
品質
Evaluated by Immunocytochemistry in HL-60 cells.
Immunocytochemistry Analysis: A 1:1,000 dilution of this antibody detected MNDA in 4% paraformaldehyde-fixed, 0.3% Triton X-100-permeabilized HL-60 cells.
Immunocytochemistry Analysis: A 1:1,000 dilution of this antibody detected MNDA in 4% paraformaldehyde-fixed, 0.3% Triton X-100-permeabilized HL-60 cells.
標靶描述
45.84 kDa calculated. ~55 kDa reported (Hudson, C.R., et al. (1988). Hybridoma. 7(6):541-553). Uncharacterized bands may be observed in some lysate(s).
外觀
Protein G purified.
Format: Purified
Purified rat monoclonal antibody IgG1 in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
儲存和穩定性
Stable for 1 year at 2-8°C from date of receipt.
其他說明
Concentration: Please refer to lot specific datasheet.
法律資訊
ALEXA FLUOR is a trademark of Life Technologies
免責聲明
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到合适的产品?
试试我们的产品选型工具.
儲存類別代碼
12 - Non Combustible Liquids
水污染物質分類(WGK)
WGK 1
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门